BioNTech, CureVac, Moderna: mRNA technology – potential to revolutionize medicine – Commerzbank column

The new “mRNA vaccines” are not only considered a major milestone in the fight against the corona pandemic – the technology behind it could even establish a completely new class of active ingredients and thus revolutionize medicine. The mRNA is figuratively speaking as a kind of “software of life”, with which everything in the body is controlled using proteins (quasi the “applications”) (the DNA would accordingly be the storage medium to remain in this analogy). Through scientific progress we know you now know how to write this software accordingly and how it can be introduced into the body cell. It can also be produced comparatively easily and made to measure. The human cell can thus be transformed into a miniaturized drug factory. In principle, mRNA can be used to produce all possible proteins in the patient’s cells, including protein molecules that cannot be produced using conventional methods or brought into the cells as active pharmaceutical ingredients. This would open up completely new treatment and prevention options. The pharmaceutical industry has long been working not only on vaccines against other infectious diseases such as Zika, but also on new solutions to treat or even cure cancer, rheumatism, multiple sclerosis, hereditary diseases or diabetes etc. There is still a long way to go us, but it should be worth it. Time will tell, but hopes have risen significantly recently, for good reasons.


Related Articles

Back to top button